One Health

metrics 2024

Transforming Health Through Collaborative Knowledge

Introduction

One Health is a premier open-access journal published by Elsevier, dedicated to advancing the interconnected disciplines of Infectious Diseases and Public Health. Established in 2015, the journal aims to promote holistic approaches to health that consider the interactions between humans, animals, and the environment. With an impressive impact factor and recognition in the top quartiles of both Infectious Diseases and Public Health categories, One Health ranks highly within the Scopus database, showcasing its significant contribution to the field. Situated in the Netherlands, the journal encourages scholarly communication and collaboration, providing a vital platform for researchers, professionals, and students to disseminate their findings and strengthen global health initiatives. By utilizing the open access model, One Health ensures that critical research is freely available, fostering a broader understanding of health-related issues that span multiple sectors.

Metrics 2024

SCIMAGO Journal Rank-
Journal Impact Factor4.10
Journal Impact Factor (5 years)4.30
H-Index-
Journal IF Without Self4.10
Eigen Factor0.00
Normal Eigen Factor0.80
Influence1.12
Immediacy Index1.10
Cited Half Life2.70
Citing Half Life6.90
JCI1.10
Total Documents-
WOS Total Citations2207
SCIMAGO Total Citations-
SCIMAGO SELF Citations-
Scopus Journal Rank-
Cites / Document (2 Years)-
Cites / Document (3 Years)-
Cites / Document (4 Years)-

Metrics History

Rank 2024

IF (Web Of Science)

INFECTIOUS DISEASES
Rank 29/132
Percentile 78.40
Quartile Q1
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Rank 53/403
Percentile 87.00
Quartile Q1

JCI (Web Of Science)

INFECTIOUS DISEASES
Rank 26/132
Percentile 80.30
Quartile Q1
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Rank 75/403
Percentile 81.39
Quartile Q1

Quartile History

Similar Journals

IJID Regions

Illuminating contemporary health challenges with innovative research.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

IJID Regions is a pioneering open access journal published by Elsevier, focusing on the critical fields of epidemiology, infectious diseases, and public health. Established in 2021, the journal aims to provide a platform for disseminating high-quality, innovative research that addresses pressing health issues and informs evidence-based practices in communities around the globe. With its impact factors reflecting a Tier Q2 and Q3 ranking in various medical subcategories on the Scopus platform, IJID Regions is positioned as a valuable resource for researchers, health professionals, and policy-makers striving to enhance public health outcomes. This journal not only champions open access since its inception, promoting the free flow of information, but also welcomes contributions that shed light on contemporary challenges in environmental and occupational health. Its commitment to fostering dialogue and collaboration in the health sciences is paramount, making it an essential read for those engaged in advancing public health knowledge and initiatives.

Lancet Regional Health-Europe

Connecting Policy, Practice, and Research in Health
Publisher: ELSEVIERISSN: 2666-7762Frequency: 12 issues/year

The Lancet Regional Health-Europe is a prestigious academic journal published by Elsevier, dedicated to advancing research in the fields of Health Policy, Internal Medicine, and Oncology. As part of a reputable series that focuses on regional health issues, it aims to publish high-quality, peer-reviewed articles that contribute to the understanding and improvement of health systems across Europe. With an impressive impact factor reflected in its Q1 quartile rankings for 2023—ranking #2 in Health Policy, #8 in Internal Medicine, and #22 in Oncology—it is recognized for its significant contribution to cutting-edge research. The journal offers open access options, ensuring that findings are widely disseminated and accessible to researchers, healthcare professionals, and policy-makers alike. By fostering collaboration and interdisciplinary discourse, The Lancet Regional Health-Europe serves as an essential platform for innovative solutions and strategies in health care that address the unique challenges faced within the European context, making it an invaluable resource for academics and practitioners dedicated to public health advancement.

Journal of Global Antimicrobial Resistance

Innovating strategies for a healthier future.
Publisher: ELSEVIER SCI LTDISSN: 2213-7165Frequency: 4 issues/year

The Journal of Global Antimicrobial Resistance, published by Elsevier Scientific Ltd, is a premier open access journal dedicated to addressing the critical issue of antimicrobial resistance on a global scale. Established in 2013 and significantly gaining traction as an open access platform since 2020, this journal serves as an essential resource for researchers, healthcare professionals, and policy makers invested in immunology, microbiology, and associated fields. With an impressive impact factor reflected through its consistent ranking in the Q2 category across multiple disciplines, including Microbiology and Immunology – where it ranks #29 out of 140 in Medical Microbiology – the journal ensures high-quality peer-reviewed articles that push the boundaries of current knowledge and practice. By offering a global perspective on research trends and public health implications, the Journal of Global Antimicrobial Resistance plays a pivotal role in advancing the scientific discourse necessary to combat the rising tide of antimicrobial resistance worldwide.

EPIDEMIOLOGY AND INFECTION

Fostering Knowledge for Global Health Challenges
Publisher: CAMBRIDGE UNIV PRESSISSN: 0950-2688Frequency: 1 issue/year

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

Transboundary and Emerging Diseases

Championing open access for impactful disease research.
Publisher: WILEY-HINDAWIISSN: 1865-1674Frequency: 1 issue/year

Welcome to Transboundary and Emerging Diseases, a prestigious journal published by WILEY-HINDAWI. With its ISSN of 1865-1674 and E-ISSN of 1865-1682, this journal plays a pivotal role in the dissemination of high-quality research within the fields of Immunology, Microbiology, Medicine, and Veterinary Sciences. Based in the United Kingdom, this open-access journal stands out with a remarkable impact factor, reflecting its category quartiles in 2023, where it secured Q1 rankings across multiple disciplines, including a remarkable rank of #3 out of 194 in Veterinary General, placing it in the top 2% of its field. With coverage spanning from 2008 to 2024, Transboundary and Emerging Diseases provides a vital platform for researchers, professionals, and students to explore emerging threats to global health and animal welfare. The journal's commitment to open access ensures broad availability of cutting-edge research, fostering collaboration and knowledge sharing in pursuit of innovative solutions to transboundary diseases. Join a community dedicated to advancing the science and practice within this crucial area of study.

Infectious Diseases Now

Innovating solutions for today's health crises.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 2666-9927Frequency: 8 issues/year

Infectious Diseases Now is a premier academic journal dedicated to the evolving field of infectious diseases, published by Elsevier France - Éditions Scientifiques Médicales Elsevier. With an ISSN of 2666-9927 and an E-ISSN of 2666-9919, this journal stands at the forefront of disseminating critical research and clinical insights from 2021 to 2024. The journal's commitment to open access means that groundbreaking studies are readily available to researchers, healthcare professionals, and students, fostering a collaborative approach to tackling global health challenges. As evidenced by its Q2 quartile ranking in the 2023 Scopus category of Infectious Diseases, and its impressive position within the top 25% of its field, Infectious Diseases Now serves as an essential resource for those involved in the study and management of infectious diseases. By publishing high-quality research, case studies, and reviews, the journal plays a pivotal role in advancing knowledge and improving patient care in this vital area of medicine.

Eurosurveillance

Empowering researchers with cutting-edge insights.
Publisher: EUR CENTRE DIS PREVENTION & CONTROLISSN: 1025-496XFrequency: 50 issues/year

Eurosurveillance is a prestigious journal dedicated to the field of epidemiology, public health, and infectious diseases, published by the European Centre for Disease Prevention and Control since 1996. With an impressive Q1 ranking across various categories, including Epidemiology and Public Health, it consistently stands at the forefront of research dissemination, making it an invaluable resource for researchers, professionals, and students alike. The journal boasts an outstanding reputation, as evidenced by its Scopus rankings, where it ranks in the top 1% to 3% in multiple relevant categories. As an Open Access publication, Eurosurveillance ensures that vital findings are freely accessible to a global audience, fostering collaboration and innovation in the fight against infectious diseases. With a dedicated reach from 2001 to 2024, the journal addresses contemporary challenges in public health and virology, reinforcing its significance in shaping policies and research initiatives across the world.

EcoHealth

Bridging Ecology and Health for a Sustainable Future
Publisher: SPRINGERISSN: 1612-9202Frequency: 4 issues/year

EcoHealth, published by Springer, is a premier academic journal at the intersection of ecology and health, dedicated to advancing our understanding of the interconnections between environmental conditions and human health. Established in 2004, the journal aims to contribute to the rapidly evolving field by publishing innovative research that addresses the complexities of socio-ecological systems. With an impressive impact factor reflecting its standing in the Q2 category for both Ecology and Health, Toxicology, and Mutagenesis, EcoHealth is highly regarded among researchers and practitioners alike. The journal’s inclusion in top-tier Scopus rankings—125th out of 461 in Environmental Science _ Ecology and 77th out of 148 in Environmental Science _ Health, Toxicology and Mutagenesis—further underscores its significance in the scientific community. EcoHealth is committed to facilitating open discussions and interdisciplinary collaboration, making it an essential resource for students, researchers, and professionals seeking to explore the critical linkages between ecological integrity and public health.

Microbial Risk Analysis

Connecting Scholars to Combat Microbial Threats
Publisher: ELSEVIERISSN: 2352-3522Frequency: 3 issues/year

Microbial Risk Analysis, published by Elsevier, is a pivotal academic journal specializing in the intersection of epidemiology, infectious diseases, and medical microbiology. With an ISSN of 2352-3522 and an E-ISSN of 2352-3530, this journal has been contributing to the field since its inception in 2016 and continues to invite groundbreaking research as it converges through 2024. With a respectable impact factor, Microbial Risk Analysis holds a Q3 designation in key categories, showcasing its credibility with ranks such as #48 in Epidemiology and #124 in Infectious Diseases according to Scopus. The journal serves as an essential platform for researchers, professionals, and students alike, aiming to enhance understanding of microbial risks and their public health implications. Although it operates under a subscription model, its contents remain accessible to a broad range of interdisciplinary scholars dedicated to advancing microbial research. For those at the forefront of epidemiological and infectious disease studies, Microbial Risk Analysis represents a crucial resource for disseminating knowledge and fostering collaboration.

Revista de Salud Ambiental

Connecting Science and Policy for Public Health Progress
Publisher: SOC ESPANOLA SANIDAD AMBIENTALISSN: 1577-9572Frequency: 2 issues/year

Revista de Salud Ambiental is a prestigious scientific journal dedicated to advancing knowledge in the field of environmental health. Published by the SOC ESPANOLA SANIDAD AMBIENTAL, this Open Access journal has been providing free access to its articles since 2001, ensuring that critical research on environmental influences on public health is widely available to researchers, professionals, and students worldwide. With an ISSN of 1577-9572 and E-ISSN 1697-2791, the journal covers a broad range of topics including environmental toxins, pollution management, and sustainable public health practices. Its commitment to high-quality research is reflected in its rigorous peer-review process, aiming to drive significant advancements in environmental health science. By promoting interdisciplinary collaboration and dissemination of impactful research, Revista de Salud Ambiental plays a vital role in shaping environmental health policies and practices, making it an essential resource for anyone invested in the future of public health.